The rising number of sports injuries and technological advancements in electrotherapy systems are expected to boost the growth of the global electrotherapy market at a CAGR of 3.80% during the forecast period, 2023 to 2030

Global Electrotherapy Market to Reach USD 1.30 Billion by 2035, Registering a CAGR of 3.82% During 2025–2035

Market Research Future (MRFR) has published a cooked research report on the “Global Electrotherapy Market” containing information from 2020 to 2035. The market is projected to register a CAGR of 3.82% during the forecast period (2025–2035).

MRFR recognizes the following companies as the key players in the Global Electrotherapy Market — Medtronic plc (Ireland), Alimed, Cogentix Medical, Jude Medical, Zynex Medical (US), DJO Global Inc. (US), Livanova Plc (UK), Nervo Corp (US), Neuromextrix Inc. (US), and Boston Scientific Corporation (US).

Market Highlights

According to MRFR analysis, the Global Electrotherapy Market was valued at USD 0.86 Billion in 2024 and is projected to grow from USD 0.89 Billion in 2025 to USD 1.30 Billion by 2035, at a CAGR of 3.82% during the forecast period.

Growth is primarily driven by the rising frequency of sports injuries, technological advancements, and increased healthcare expenditure. The Transcutaneous Electrical Nerve Stimulation (TENS) therapy segment dominated the market in 2022, owing to the increasing prevalence of pain injuries and sports-related conditions.

North America accounted for USD 0.36 Billion in 2022 and USD 0.86 Billion in 2024, maintaining its dominance due to the high volume of surgical procedures, rising hospital admissions, and adoption of advanced electrotherapy devices.

Segment Analysis

The Global Electrotherapy Market has been segmented based on Treatment Type, Device Type, Application, End User, and Region.

By Treatment Type, the market is segmented into Extracorporeal Shock Wave Therapy, Interferential Current Therapy (IC), Magnetic Field Therapy, Ultrasound Therapy, Transcutaneous Electrical Nerve Stimulation (TENS) Therapy, and Micro-Current Therapy.The Transcutaneous Electrical Nerve Stimulation (TENS) therapy segment held the largest share in 2022, driven by the rising prevalence of chronic pain and musculoskeletal injuries. TENS therapy is widely used for arthritis, neck and back pain, and deep tissue injuries resulting from sports activities.

By Device Type, the market is segmented into Transcutaneous Electrical Neural Stimulation (TENS), Electronic Muscle Stimulator (EMS), Interferential Stimulator (IF), and High Voltage Pulsed Galvanic Stimulator (HVPGS).The Transcutaneous Electrical Neural Stimulation (TENS) segment dominated in 2022 and is projected to be the fastest-growing device segment during 2023–2032, driven by ease of use and expanding pain management applications.

The application segment is divided into Pain Management, Neuromuscular Dysfunction, Urine and Fecal Incontinence, Acute and Chronic Edema, Tissue Repair, Iontophoresis, Orthopedics, and Cardiology. The Pain Management segment held the largest share in 2022 and is projected to grow fastest through 2030. Increasing prevalence of chronic pain, combined with new device approvals and product launches, is driving this segment’s growth.

The market, by end-user, is segmented into Hospitals & Clinics, Rehabilitation Centers, Long-Term Care Centers, and Others.The Hospitals & Clinics segment led the market in 2022, supported by rapid adoption of advanced electrotherapy systems and rising government initiatives to improve healthcare infrastructure.

Regional Analysis

The Global Electrotherapy Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.

North America dominates the market, accounting for USD 0.36 Billion in 2022, driven by rising sports injuries, increased surgeries, and growing adoption of non-invasive pain management devices. The U.S. leads the region, followed by Canada.

Europe holds the second-largest share due to the availability of cutting-edge treatment facilities, government support for healthcare advancement, and an ageing population. The Germany market held the largest share, while the UK market was the fastest-growing in the region.

The Asia-Pacific market is expected to grow at the fastest CAGR from 2022 to 2030, driven by increasing rates of neuropathy, government initiatives, and a growing elderly population. The China market led the region, while India recorded the fastest growth.

The Rest of the World segment, including the Middle East, Africa, and Latin America, shows gradual adoption due to expanding healthcare investments and modernization efforts in medical technology.

Key Findings of the Study

• The Global Electrotherapy Market was valued at USD 0.86 Billion in 2024 and is projected to reach USD 1.30 Billion by 2035, expanding at a CAGR of 3.82% during 2025–2035.


• The TENS therapy segment held the largest market share in 2022.


• TENS devices also dominate the market by device type and are expected to grow fastest through the forecast period.


• Pain Management remains the leading and fastest-growing application segment.


• Hospitals & Clinics represent the dominant end-user segment due to technological adoption and increasing healthcare investments.


• North America accounted for USD 0.36 Billion in 2022, while Asia-Pacific is projected to exhibit the highest CAGR.


• Growth drivers include the rising incidence of sports injuries, increasing healthcare expenditure, technological advancements, and new product launches.


• Key players include Medtronic plc, Alimed, Cogentix Medical, Jude Medical, Zynex Medical, DJO Global Inc., Livanova Plc, Nervo Corp, Neuromextrix Inc., and Boston Scientific Corporation.

Related Report